Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Department of Urology, Onze-Lieve-Vrouwziekenhuis Hospital, Aalst, Belgium; ORSI Academy, Ghent, Belgium.
Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Eur Urol Focus. 2023 Jan;9(1):83-88. doi: 10.1016/j.euf.2022.09.003. Epub 2022 Sep 23.
Whether early ligation of the dorsal venous complex (DVC) might improve recovery of urinary continence (UC) after robot-assisted radical prostatectomy (RARP) has never been investigated in a prospective randomized study.
To assess whether early DVC ligation might affect UC recovery after RARP.
DVC ligation (early vs standard).
DESIGN, SETTING, AND PARTICIPANTS: A total of 312 patients with prostate cancer underwent primary RARP at a tertiary care institution.
The primary outcome was UC recovery at 1 and 4 mo after RARP. UC was defined as 0 pads/1 safety pad per day. All patients completed the International Prostate Symptom Score (IPSS) and International Consultation of Incontinence Questionnaire (ICIQ)-Short Form questionnaires. Secondary outcomes were early (≤4 mo) erectile function recovery, the positive surgical margin (PSM) rate, 30-d Clavien-Dindo complications, and biochemical recurrence rates. Quality of life was assessed using the EQ-5D-5L questionnaire. The association between treatment arm and UC recovery was also tested using multivariable regression models.
After surgery, 23 patients withdrew their consent and 29 were lost to follow-up, leaving 261 patients available for per-protocol analyses. Of these, 32 patients (24%) in the experimental group and 37 (29%) in the control group used no pad/one safety pad at 1 mo after RARP, whereas 96 (72%) in the control group versus 83 (65%) in the control group were continent at 4-mo follow-up (both p = 0.3). Median ICIQ and IPSS scores did not differ between the groups at both time points. The results were confirmed on multivariable regression analyses. PSMs were observed for 32 patients (25%) in the experimental group versus 30 (22%) in the control group (p = 0.6). The incidence of postoperative complications (17% experimental vs 13% control) and the 1-yr biochemical recurrence-free survival did not differ between the groups.
In this randomized clinical trial, we did not find evidence that early ligation of the DVC during RARP was associated with better UC recovery after surgery in comparison to the standard technique. Given its safety in terms of surgical margins and complications, this technique may be considered as an option for surgical dissection according to the physician's preference.
Our trial showed that for patients undergoing robot-assisted surgical removal of the prostate, the timing of a specific step to control bleeding from a network of veins draining the prostate did not affect recovery of urinary continence after surgery. The results indicate that earlier control of these veins may be considered as an option according to the surgeon's preference.
经尿道前列腺切除术(RARP)后早期结扎背静脉复合体(DVC)是否能改善尿控(UC)的恢复,这在前瞻性随机研究中从未被研究过。
评估 DVC 早期结扎是否会影响 RARP 后的 UC 恢复。
DVC 结扎(早期与标准)。
设计、地点和参与者:共有 312 例前列腺癌患者在一家三级医疗机构接受了原发性 RARP。
主要结局是 RARP 后 1 个月和 4 个月时的 UC 恢复情况。UC 定义为每天 0 片/1 片安全垫。所有患者均完成国际前列腺症状评分(IPSS)和国际尿失禁咨询问卷-短表(ICIQ-SF)问卷。次要结局是早期(≤4 个月)勃起功能恢复、阳性切缘(PSM)率、30 天 Clavien-Dindo 并发症和生化复发率。使用 EQ-5D-5L 问卷评估生活质量。还使用多变量回归模型测试了治疗臂与 UC 恢复之间的关联。
手术后,23 名患者撤回了同意,29 名患者失访,261 名患者可进行方案分析。其中,实验组 32 名患者(24%)和对照组 37 名患者(29%)在 RARP 后 1 个月时使用 1 片/1 片安全垫,而对照组 96 名患者(72%)和对照组 83 名患者(65%)在 4 个月随访时尿控(均 p=0.3)。两组在两个时间点的 ICIQ 和 IPSS 评分中位数均无差异。多变量回归分析结果证实了这一点。实验组 32 名患者(25%)和对照组 30 名患者(22%)出现 PSM(p=0.6)。实验组术后并发症发生率(17%)与对照组(13%)无差异。1 年生化无复发生存率也无差异。
在这项随机临床试验中,我们没有发现与标准技术相比,在 RARP 期间早期结扎 DVC 与术后 UC 恢复更好相关的证据。鉴于在手术切缘和并发症方面的安全性,根据医生的偏好,该技术可作为手术解剖的一种选择。
我们的试验表明,对于接受机器人辅助前列腺切除术的患者,控制引流前列腺静脉网络出血的特定步骤的时间不会影响手术后尿控的恢复。结果表明,根据外科医生的偏好,更早地控制这些静脉可能是一种选择。